aortic valve replacement

Is Rehospitalization a Relevant Factor after Aortic Valve Replacement?

Patients with severe symptomatic aortic stenosis treated with aortic valve replacement might still present cardiac failure, even after successful procedures.&nbsp;&nbsp; According to some reports, the incidence of cardiac failure after TAVR varies between 9% and 24%. The prognostic relevance of rehospitalization in these patients has not been studied yet; in fact, it remains unclear whether<a href="https://solaci.org/en/2023/01/19/is-rehospitalization-a-relevant-factor-after-aortic-valve-replacement/" title="Read more" >...</a>

EuroPCR 2022 | Cambios en el daño cardíaco luego del reemplazo valvular aórtico por cirugía

EuroPCR 2022 | Changes in Cardiac Damage after Surgical Aortic Valve Replacement

This study presented at EuroPCR 2022 analyzed the PARTNER study pool and included 1974 patients with a complete echocardiogram. Surgical risk was 17.3% extreme/inoperable, 54.3% intermediate and 28.4% low. 60% received transcatheter aortic valve replacement (TAVR) and the rest surgical aortic valve replacement (SAVR).&nbsp; 6.1% of patients were in stage 0 (no damage), 14.5% were<a href="https://solaci.org/en/2022/05/19/europcr-2022-changes-in-cardiac-damage-after-surgical-aortic-valve-replacement/" title="Read more" >...</a>

Sangrado y mortalidad en el reemplazo valvular aórtico por catéter

Frailty and Bleeding: Impact on Aortic Valve Replacement

Courtesy of Dr. Carlos Fava. We are well aware that both transcatheter aortic valve replacement (TAVR) and surgical valve replacement (SAVR) generate bleeding (15% to 22% for TAVR and 22% to 44% for SAVR).&nbsp; Frail patients constitute a particular group. These have not yet been assessed as to the real risk they run and mortality<a href="https://solaci.org/en/2020/06/09/frailty-and-bleeding-impact-on-aortic-valve-replacement/" title="Read more" >...</a>

Remodelado miocárdico reverso luego del reemplazo valvular

Loss in Life Expectancy after Surgical Aortic Valve Replacement

This study found after surgical aortic valve replacement (SAVR) patients had shorter life expectancy, compared against the general population. This loss in life expectancy was significant, especially in young patients. These results provide essential information to advice patients before and after SAVR. This is an observational national cohort study to assess long term relative survival<a href="https://solaci.org/en/2019/07/18/loss-in-life-expectancy-after-surgical-aortic-valve-replacement/" title="Read more" >...</a>

Sangrado y mortalidad en el reemplazo valvular aórtico por catéter

Bleeding and Mortality in Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR)&nbsp;is much less invasive than surgical replacement. This is associated with a substantial reduction in&nbsp;bleeding events (up to 60% less). However, clinically relevant bleeding is still present in one every four patients who undergo TAVR, which is associated with morbidity and mortality. &nbsp; Cases of bleeding are not uniform: they may<a href="https://solaci.org/en/2017/08/22/bleeding-and-mortality-in-transcatheter-aortic-valve-replacement/" title="Read more" >...</a>

El TAVI presenta menos IAM post procedimiento que la cirugía de reemplazo valvular aórtico

TAVR presents less post-procedural MI than surgical aortic valve replacement

Courtesy of Dr. Carlos Fava. Surgical aortic valve replacement (SAVR) continues to be elective, but the presence of post-procedural acute myocardial infarction (AMI) has been associated to bad evolution. Despite the proven benefits of TAVR for high risk patients and the progress shown by patients of intermediate risk, the incidence of post implantation MI has<a href="https://solaci.org/en/2017/06/13/tavr-presents-less-post-procedural-mi-than-surgical-aortic-valve-replacement/" title="Read more" >...</a>

Estenosis aórtica moderada y disfunción ventricular ¿debería apurarse la indicación del recambio?

Moderate Aortic Stenosis and Ventricular Dysfunction: Should Valve Replacement Come Sooner?

Ventricular dysfunction and moderate aortic stenosis are more frequent with advancing age and often coexist. Afterload reduction is one of the main pillars of pharmacological treatment of heart failure, and aortic stenosis (even that of moderate severity) increases the afterload. Nowadays, aortic valve replacement is only formally indicated for symptomatic severe aortic stenosis. &nbsp; This<a href="https://solaci.org/en/2017/05/25/moderate-aortic-stenosis-and-ventricular-dysfunction-should-valve-replacement-come-sooner/" title="Read more" >...</a>

Mejoras tecnológicas en las válvulas que se traducen en resultados clínicos

TAVR in Intermediate-Risk Patients: Is It as Effective as Surgical Aortic Valve Replacement?

Courtesy of Dr. Carlos&nbsp;Fava. Transcatheter aortic valve replacement (TAVR) has proven to be beneficial for extreme- and high-risk patients. It is also increasingly used in intermediate-risk patients, and it has been hinted at for low-risk patients. However, different sectors in the medical community still challenge the existence of real TAVR benefit. &nbsp; This assessment consisted<a href="https://solaci.org/en/2017/05/03/tavr-in-intermediate-risk-patients-is-it-as-effective-as-surgical-aortic-valve-replacement/" title="Read more" >...</a>

Top